Physician profile
Thaw Sint
NPI 1891893186
$2,493.05
in general payments reported to CMS, 2019-2025
19 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $272 · 2021: $185 · 2022: $127 · 2023: $563 · 2024: $415 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.70 |
| Education | $184.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $705.74 | 2019-2025 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $443.86 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $417.96 | 2023-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.16 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $138.58 | 2019-2022 | |
| Itamar Medical INC | $105.15 | 2021-2023 | Watchpatone |
| Sanofi-Aventis U.S. LLC | $84.99 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $72.18 | 2019-2022 | |
| Insmed, INC. | $60.89 | 2024-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $53.65 | 2019 | |
| Inspire Medical Systems, INC. | $47.48 | 2023-2024 | Inspire |
| Mylan Specialty L.P. | $40.11 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $26.19 | 2019 | |
| United Therapeutics Corporation | $25.28 | 2023 | Tyvaso |
| Gilead Sciences, INC. | $20.85 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $20.83 | 2023 | Inogen |
| Philips North America LLC | $18.55 | 2019 | |
| Allergan, INC. | $16.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thaw Sint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.